Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ekberg

Showing results (21-30 of 128) with videos related to

Pageof 13
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Impaired renal artery blood flow at transplantation is correlated to delayed onset of graft functionA Lundell, N H Persson, R Källen, et al.
Transplantation|June 3, 2000
Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejectionH Ekberg, P J Svensson, M Simanaitis, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|March 1, 1987
Site and number of liver tumors recorded at angiography and computed tomography compared with the findings at laparotomy and of resected liver specimensC Lundstedt, H Ekberg, A Lunderquist, et al.
Scandinavian Journal of Immunology|November 26, 2003
Two doses of daclizumab in conjunction with low-dose cyclosporine, mycophenolate mofetil and steroids resulted in a low incidence of acute rejection after renal transplantationH Ekberg, N H Persson, R Källen, et al.
Transplant Immunology|January 18, 2006
Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection--implications for development of a possible diagnostic markerC Osterholm, B Veress, M Simanaitis, et al.
Scandinavian Journal of Urology and Nephrology|January 27, 2005
Renal replacement therapy in SwedenS Schön, H Ekberg, B Wikström, et al.
Scandinavian Journal of Immunology|April 1, 1997
Mycophenolate mofetil, azathioprine and cyclophosphamide enhanced efficacy combined with cyclosporine in rat cardiac transplantationO Ostraat, Z Qi, M Olausson, et al.
Transplantation Proceedings|December 1, 1992
Drug exposure and flow cytometry analyses in a thalidomide treatment schedule that prolongs rat cardiac graft survivalT Eriksson, K Riesbeck, O Ostraat, et al.
Transplantation Proceedings|December 1, 1992
Thalidomide prolongs graft survival in rat cardiac transplantsO Ostraat, H Ekberg, H Schatz, et al.
Transplantation|November 22, 2000
Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejectionY Vanrenterghem, Y Lebranchu, R Hené, et al.
Pageof 13

Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Impaired renal artery blood flow at transplantation is correlated to delayed onset of graft functionA Lundell, N H Persson, R Källen, et al.
Transplantation|June 3, 2000
Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejectionH Ekberg, P J Svensson, M Simanaitis, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|March 1, 1987
Site and number of liver tumors recorded at angiography and computed tomography compared with the findings at laparotomy and of resected liver specimensC Lundstedt, H Ekberg, A Lunderquist, et al.
Scandinavian Journal of Immunology|November 26, 2003
Two doses of daclizumab in conjunction with low-dose cyclosporine, mycophenolate mofetil and steroids resulted in a low incidence of acute rejection after renal transplantationH Ekberg, N H Persson, R Källen, et al.
Transplant Immunology|January 18, 2006
Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection--implications for development of a possible diagnostic markerC Osterholm, B Veress, M Simanaitis, et al.
Scandinavian Journal of Urology and Nephrology|January 27, 2005
Renal replacement therapy in SwedenS Schön, H Ekberg, B Wikström, et al.
Scandinavian Journal of Immunology|April 1, 1997
Mycophenolate mofetil, azathioprine and cyclophosphamide enhanced efficacy combined with cyclosporine in rat cardiac transplantationO Ostraat, Z Qi, M Olausson, et al.
Transplantation Proceedings|December 1, 1992
Drug exposure and flow cytometry analyses in a thalidomide treatment schedule that prolongs rat cardiac graft survivalT Eriksson, K Riesbeck, O Ostraat, et al.
Transplantation Proceedings|December 1, 1992
Thalidomide prolongs graft survival in rat cardiac transplantsO Ostraat, H Ekberg, H Schatz, et al.
Transplantation|November 22, 2000
Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejectionY Vanrenterghem, Y Lebranchu, R Hené, et al.
Pageof 13